TWO SIGMA INVESTMENTS, LP - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 342 filers reported holding INTELLIA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.72 and the average weighting 0.4%.

Quarter-by-quarter ownership
TWO SIGMA INVESTMENTS, LP ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$5,185,364
+196.4%
163,990
+282.3%
0.01%
+250.0%
Q2 2023$1,749,462
-66.5%
42,900
-69.4%
0.00%
-73.3%
Q1 2023$5,223,689
-25.3%
140,158
-30.1%
0.02%
-31.8%
Q4 2022$6,992,444
+36.4%
200,414
+118.8%
0.02%
+29.4%
Q3 2022$5,126,000
-76.4%
91,595
-78.2%
0.02%
-76.4%
Q2 2022$21,765,000
-37.4%
420,503
-12.1%
0.07%
-30.1%
Q1 2022$34,755,000
+48.3%
478,253
+141.3%
0.10%
+106.0%
Q4 2021$23,431,000
-43.7%
198,161
-36.1%
0.05%
-46.2%
Q3 2021$41,607,000
+448.6%
310,154
+562.1%
0.09%
+447.1%
Q2 2021$7,584,000
-72.7%
46,842
-86.5%
0.02%
-76.4%
Q1 2021$27,825,000
+80.0%
346,704
+22.0%
0.07%
+63.6%
Q4 2020$15,457,000
+212.2%
284,138
+14.1%
0.04%
+144.4%
Q3 2020$4,951,000
-13.4%
249,020
-8.5%
0.02%
-35.7%
Q2 2020$5,718,000
+193.7%
272,014
+70.9%
0.03%
+75.0%
Q1 2020$1,947,000
-53.2%
159,194
-43.8%
0.02%
+23.1%
Q4 2019$4,159,000
+253.1%
283,487
+221.2%
0.01%
+225.0%
Q3 2019$1,178,000
-36.2%
88,254
-21.8%
0.00%
-33.3%
Q2 2019$1,847,000
-8.7%
112,821
-23.9%
0.01%
-25.0%
Q4 2018$2,024,000148,2610.01%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders